Table 4.

Hyperfluorescent Areas, RPE Atrophy With and Without Outer Nuclear Layer Atrophy in GA, STGD, and Pattern Dystrophy

A.
	RPE Atrophy	RPE Atrophy
	With Outer	Without Outer
Channel	Nuclear Layer Atrophy	Nuclear Layer Atrophy	Unaffected Areas	P
SSC	589 ± 178 ps	431 ± 173 ps	327 ± 79 ps	<0.001
LSC	687 ± 159 ps	550 ± 160 ps	417 ± 75 ps	<0.001
B.
Disease	Channel	Hyperfluorescent Areas	Atrophic Areas	P
GA (n = 32 eyes)	SSC	388 ± 99 ps	523 ± 178 ps	<0.001
	LSC	507 ± 88 ps	609 ± 130 ps	<0.001
STGD (n = 66 eyes)	SSC	285 ± 81 ps	301 ± 169 ps	0.327
	LSC	352 ± 81 ps	385 ± 143 ps	<0.05
Pattern dystrophy (n = 18 eyes)	SSC	295 ± 61 ps	342 ± 191 ps	0.271
	LSC	338 ± 74 ps	397 ± 145 ps	0.117
			Non-Atrophic, Normal
Disease	Channel	Hyperfluorescent Areas	Fluorescent Areas	P
GA (n = 32 eyes)	SSC	388 ± 99 ps	322 ± 79 ps	<0.001
	LSC	507 ± 88 ps	421 ± 75 ps	<0.001
STGD (n = 66 eyes)	SSC	285 ± 81 ps	197 ± 70 ps	<0.001
	LSC	352 ± 81 ps	268 ± 89 ps	<0.001
Pattern dystrophy (n = 18 eyes)	SSC	295 ± 61 ps	233 ± 44 ps	<0.001
	LSC	338 ± 74 ps	283 ± 49 ps	<0.01

Part A shows results from an analysis of variance among the different atrophic areas, specifically areas with RPE atrophy with and without outer nuclear layer atrophy, compared with unaffected areas. Part B shows Bonferroni-corrected P values of differences between hyperfluorescent areas and atrophic areas, as well as hyperfluorescent areas and unaffected areas. Both spectral channels (SSC, 498–560 nm; LSC, 560–720 nm) are shown.